These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 26539631)
1. The curative management of synchronous rectal and prostate cancer. Lavan NA; Kavanagh DO; Martin J; Small C; Joyce MR; Faul CM; Kelly PJ; O'Riordain M; Gillham CM; Armstrong JG; Salib O; McNamara DA; McVey G; O'Neill BD Br J Radiol; 2016; 89(1057):20150292. PubMed ID: 26539631 [TBL] [Abstract][Full Text] [Related]
2. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer. Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851 [TBL] [Abstract][Full Text] [Related]
3. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788 [TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
5. Management of locally advanced synchronous colorectal and prostate cancers: A case report. Tey YQ; Ravi K; Chong CS; Chiong E; Ho J; Tey JCS; Ho F Medicine (Baltimore); 2020 May; 99(22):e20336. PubMed ID: 32481410 [TBL] [Abstract][Full Text] [Related]
6. Management of synchronous rectal and prostate cancer. Kavanagh DO; Quinlan DM; Armstrong JG; Hyland JM; O'Connell PR; Winter DC Int J Colorectal Dis; 2012 Nov; 27(11):1501-8. PubMed ID: 22451255 [TBL] [Abstract][Full Text] [Related]
7. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related]
8. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
9. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation. Vicini FA; Kestin LL; Martinez AA Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815 [TBL] [Abstract][Full Text] [Related]
10. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes? Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365 [TBL] [Abstract][Full Text] [Related]
11. Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy. Price JG; Stone NN; Stock RG Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):842-7. PubMed ID: 23845840 [TBL] [Abstract][Full Text] [Related]
12. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305 [TBL] [Abstract][Full Text] [Related]
14. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis. Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247 [TBL] [Abstract][Full Text] [Related]
15. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy. Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108 [TBL] [Abstract][Full Text] [Related]
16. Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma. Buckstein M; Kerns S; Forysthe K; Stone NN; Stock RG BJU Int; 2013 Mar; 111(3 Pt B):E43-7. PubMed ID: 23046084 [TBL] [Abstract][Full Text] [Related]
17. Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer. Tan J; Heriot AG; Mackay J; Van Dyk S; Bressel MA; Fox CD; Hui AC; Lynch AC; Leong T; Ngan SY J Med Imaging Radiat Oncol; 2013 Oct; 57(5):617-25. PubMed ID: 24119279 [TBL] [Abstract][Full Text] [Related]
18. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy. Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815 [TBL] [Abstract][Full Text] [Related]
19. Interstitial high-dose-rate brachytherapy as a boost in synchronous prostate and rectal cancer treatment: case report and literature review. Konat-Bąska K; Chicheł A; Staszek-Szewczyk U; Maciejczyk A; Matkowski R J Contemp Brachytherapy; 2020 Apr; 12(2):181-187. PubMed ID: 32395143 [TBL] [Abstract][Full Text] [Related]
20. Technological advances in radiotherapy for the treatment of localised prostate cancer. Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]